POVAN Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Povan, and what generic alternatives are available?
Povan is a drug marketed by Parke Davis and is included in two NDAs.
The generic ingredient in POVAN is pyrvinium pamoate. Additional details are available on the pyrvinium pamoate profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for POVAN?
- What are the global sales for POVAN?
- What is Average Wholesale Price for POVAN?
Summary for POVAN
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 2 |
| DailyMed Link: | POVAN at DailyMed |
US Patents and Regulatory Information for POVAN
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Parke Davis | POVAN | pyrvinium pamoate | SUSPENSION;ORAL | 011964-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Parke Davis | POVAN | pyrvinium pamoate | TABLET;ORAL | 012485-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
